• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

The Impact Of Derailing The WHO Medical R&D Convention

19/06/2013 by Intellectual Property Watch 1 Comment

An article in the newly launched Journal of Health Diplomacy about the stalled progress at the World Health Organization for a medical research and development (R&D) convention discusses systemic failures in global health policy.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, English, Health & IP, Human Rights, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

EIFL Guide To The European Orphan Works Directive

19/06/2013 by Intellectual Property Watch Leave a Comment

A guide to key provisions and limitations of the European Union directive on permitted uses of orphan works – those whose creators cannot be found – has been published by the Electronic Information for Libraries (EIFL).

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Europe, Innovation/ R&D, Lobbying

WIPO Seminar Discusses Impact Of TRIPS On Pharmaceutical Innovation

19/06/2013 by Brittany Ngo for Intellectual Property Watch Leave a Comment

The latest instalment of the World Intellectual Property Organization seminar series titled “The Economics of Intellectual Property” covered the issue of product patents in the pharmaceutical industry. Discussion focussed on the economics of intellectual property rights and how pharmaceutical patent protection might not be the sole culprit in the access to innovation problem.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, English, Finance, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO, WIPO, WTO/TRIPS

US Businesses Launch Coalition For Fair Trade With India

18/06/2013 by Kelly Burke for Intellectual Property Watch 2 Comments

A new coalition of United States business groups, called the Alliance for Fair Trade with India (ATFI), launched today to take aim against what they say are discriminatory trade practices in India against US exports.

Filed Under: IP Policies, Language, Themes, Venues, Copyright Policy, Enforcement, English, Lobbying, North America, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains

G8 Hails Trade Deals, Nods To WTO, Issues Declaration On Open Data

18/06/2013 by Monika Ermert for Intellectual Property Watch Leave a Comment

In their traditional communiqué, Group of Eight countries at their annual summit welcomed ongoing efforts to negotiate bilateral and multilateral trade deals which they say will allow them to overcome economic uncertainties and shoulder the responsibility to support prosperity worldwide.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Access to Knowledge/ Education, Bilateral/Regional Negotiations, Copyright Policy, Enforcement, English, Europe, North America, WTO/TRIPS

Good Intentions Echo In Marrakesh At Start Of Negotiations On Treaty For The Blind

18/06/2013 by Catherine Saez, Intellectual Property Watch Leave a Comment

The World Intellectual Property Organization diplomatic conference expected to yield a treaty creating exceptions and limitations to copyright for the benefit of visually impaired people opened today in Marrakesh, Morocco.

Assurances of good faith and willingness to find solutions for remaining issues were given by delegates, while WIPO Director General Francis Gurry called for unity, King Mohammed VI talked about moral obligation in a royal message, and visually impaired people called for negotiators to create history. All nonetheless agreed on the importance of the copyright system.

Filed Under: Features, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Human Rights, Innovation/ R&D, Technical Cooperation/ Technology Transfer, WIPO

US Supreme Court Rules On Pharma Payments To Delay Generic Drugs On Market

17/06/2013 by Catherine Saez, Intellectual Property Watch Leave a Comment

The United States Supreme Court in a five to three decision today found that settlement agreements by branded pharmaceutical companies involving payments to generic companies to delay their cheaper drugs’ entry into the market may not be immune from antitrust scrutiny but are not “presumptively” unlawful. The case was sent back to lower court.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Access to Knowledge/ Education, English, Health & IP, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

US Supreme Court Restricts Gene Patents … A Little

17/06/2013 by Steven Seidenberg for Intellectual Property Watch 2 Comments

Last Thursday, the United States Supreme Court overturned more than 30 years of precedents and ruled that isolated genes cannot be patented. They are products of nature and thus not patent-eligible subject matter, the court unanimously held in Assoc. for Molecular Pathology v. Myriad Genetics, Inc. This ruling puts the US at odds with most other nations, which allow genes to be patented. But because other major nations grant narrower gene patents, the net effect of Myriad will be to shift the US position on gene patents closer to that of other nations.

Filed Under: IP Policies, Subscribers, Themes, Venues, Access to Knowledge/ Education, Biodiversity/Genetic Resources/Biotech, English, Health & IP, Human Rights, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Perspectives on the US

At G8: EU, US Kick Off Bilateral Trade Negotiations

17/06/2013 by Intellectual Property Watch Leave a Comment

During day one of the Summit of the G8 countries at Lough Erne Golf Resort in Enniskillen, Northern Ireland today, President Barack Obama, British Prime Minister David Cameron and the President of the European Commission, Manuel Barroso, jointly announced the formal start of negotiations of the US-EU free trade agreement, the Transatlantic Trade and Investment Partnership (TTIP).

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Bilateral/Regional Negotiations, Copyright Policy, Enforcement, English, Europe, North America, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains

Group Of Experts Looks At High Price Of Cancer Drugs

17/06/2013 by Intellectual Property Watch Leave a Comment

Prices of cancer drugs must be lowered to be affordable for patients and to maintain sound long-term healthcare policies, according to a group of chronic myeloid leukemia (CML) experts in a recent Blood journal editorial.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

  • « Previous Page
  • 1
  • …
  • 346
  • 347
  • 348
  • 349
  • 350
  • …
  • 714
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2026 · Global Policy Reporting